Asterios Deligiannis | Medicine | Best Innovation Award

Published on by Scientific World Research Awards

Best Innovation Award

Asterios Deligiannis

Researcher Information
Affiliation Aristotle University of Thessaloniki
Country Greece
Scopus ID 7003501457
Documents 127
Citations 5,944
h-index 28
Subject Area Chemistry
Event Scientific World Research Awards
ORCID 0000-0001-7765-1897

Asterios Deligiannis is an academic affiliated with Aristotle University of Thessaloniki, Greece. His scholarly record demonstrates extensive research productivity, interdisciplinary collaboration, and sustained scientific contribution. According to available research metrics, he has produced 127 indexed publications, received 5,944 citations, and achieved an h-index of 28, reflecting broad academic visibility and influence across multiple research domains.[1][2]

Abstract

This article presents an overview of the academic achievements of Asterios Deligiannis. His research portfolio encompasses a substantial body of scholarly work, international collaborations, and contributions to scientific knowledge. Available publication metrics indicate 127 indexed documents, 5,944 citations, and an h-index of 28, reflecting sustained research productivity and scholarly influence.[1] His academic activities include participation in international research initiatives, professional organizations, and peer-reviewed publications. These accomplishments demonstrate innovation, research leadership, and measurable scientific impact, supporting consideration for recognition through the Best Innovation Award within an international academic framework.[2]

Keywords

Innovation, Chemistry, Scientific Research, Academic Impact, Research Excellence, Scholarly Contributions.

Introduction

Research innovation is commonly assessed through scientific productivity, influence, and contributions to knowledge development. Academic recognition programs frequently consider publication records, citation performance, and interdisciplinary engagement when evaluating researchers for distinguished awards.[1]

Research Profile

Deligiannis is affiliated with Aristotle University of Thessaloniki and maintains an active ORCID record. His professional activities include academic leadership, international memberships, and participation in collaborative research programs.[2]

Research Contributions

His scholarly contributions span cardiovascular health, exercise-related investigations, rehabilitation studies, and interdisciplinary scientific research. Numerous peer-reviewed publications demonstrate long-term engagement in advancing evidence-based knowledge and innovation.[3]

Publications

The researcher has authored 127 indexed publications and contributed to a broad collection of scientific articles published in international journals. His publication record reflects sustained scholarly activity and extensive collaboration across research communities.[1]

Research Impact

Research influence is demonstrated through 5,944 citations and an h-index of 28. These indicators suggest significant academic visibility and continuing relevance of his publications within scientific literature and research networks.[1]

Award Suitability

The combination of research productivity, scholarly impact, international engagement, and documented scientific contributions supports consideration for the Best Innovation Award. His profile reflects characteristics commonly associated with academic distinction and innovation-oriented recognition.[1]

Conclusion

Asterios Deligiannis has established a substantial academic record characterized by impactful publications, collaborative research activities, and measurable scholarly influence. These achievements provide a strong foundation for recognition within international research award programs.

References

  1. Elsevier. (n.d.). Scopus Author Details: Asterios Deligiannis, Author ID 7003501457. Scopus.

    https://www.scopus.com/authid/detail.uri?authorId=7003501457

  2. ORCID. (2026). Asterios Deligiannis ORCID Record.

    https://orcid.org/0000-0001-7765-1897

  3. Deligiannis, A., et al. (2025). Investigating the Role of Exercise in Improving Bone Health Among Elderly Women with Osteopenia.

    https://doi.org/10.3390/jfmk10040451

  4. Deligiannis, A., et al. (2025). Advanced Stress Echocardiography with Cardiopulmonary Exercise Testing After Myocardial Infarction.

    https://doi.org/10.3390/jfmk10040393

  5. Scientific World Research Awards. (n.d.). Official Award Information Portal.

    https://scientificworld.net/

Yoshiya Tanaka | Medicine | Innovative Research Award

Published on by Scientific World Research Awards

Innovative Research Award

Yoshiya Tanaka

Yoshiya Tanaka
Affiliation Hospital of University of Occupational and Environmental Health
Country Japan
Scopus ID 56328279400
Documents 1,326
Citations 50,831
h-index 99
Subject Area Medicine
Event Scientific World Research Awards

Yoshiya Tanaka, Hospital of University of Occupational and Environmental Health, Japan, is recognized for substantial contributions to rheumatology, immunology, and autoimmune disease research. His scholarly output, clinical investigations, and leadership in international collaborations have supported advancements in evidence-based medical practice and therapeutic development.[1]

Abstract

The Innovative Research Award recognizes researchers whose work demonstrates sustained scientific excellence and measurable impact. Yoshiya Tanaka has contributed extensively to rheumatology and clinical immunology through studies on autoimmune diseases, inflammatory mechanisms, biologic therapies, and targeted treatments. His research has informed clinical guidelines, improved disease classification systems, and supported the development of therapeutic strategies for conditions such as systemic lupus erythematosus, rheumatoid arthritis, and IgG4-related disease. With a substantial publication record and broad international collaboration, his work has influenced both academic research and patient care, reflecting the objectives of the Scientific World Research Awards.[1][2]

Keywords

Rheumatology, Clinical Immunology, Autoimmune Diseases, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Biologic Therapy, Translational Medicine.

Introduction

Modern rheumatology depends on interdisciplinary research linking immunology, molecular biology, and clinical practice. Yoshiya Tanaka has participated in investigations that enhanced understanding of inflammatory pathways and treatment approaches for immune-mediated diseases.[3]

Research Profile

As Professor and Chairman in rheumatology and clinical immunology, Tanaka has developed a research portfolio focused on disease mechanisms, therapeutic innovation, and clinical trial leadership. His scholarly record reflects long-term engagement with translational medicine and global collaboration.[1]

Research Contributions

Key contributions include studies supporting lupus classification criteria, IgG4-related disease frameworks, Janus kinase inhibitor development, and biologic treatment evaluation. These efforts have contributed to improved disease assessment and therapeutic decision-making.[2][4]

Publications

  • 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus.
  • Trial of Anifrolumab in Active Systemic Lupus Erythematosus.
  • Janus Kinase-Targeting Therapies in Rheumatology.

Research Impact

The researcher’s publications have received extensive citations, demonstrating influence across clinical medicine and immunology. Findings from collaborative studies have informed guidelines, therapeutic development, and evidence-based healthcare practices internationally.[1][5]

Award Suitability

The breadth of scientific output, citation performance, clinical relevance, and leadership in collaborative research aligns with the objectives of the Innovative Research Award. His contributions demonstrate sustained scholarly influence and practical significance in medicine.

Conclusion

Yoshiya Tanaka’s career reflects a consistent commitment to advancing knowledge in rheumatology and autoimmune disease research. His achievements support recognition within international scientific award programs and academic communities.

References

  1. Elsevier. (n.d.). Scopus author details: Yoshiya Tanaka, Author ID 56328279400. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56328279400
  2. Aringer, M., et al. (2019). 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus.
    DOI: https://doi.org/10.1002/art.40930
  3. Tanaka, Y., Adams, D.H., & Shaw, S. (1993). T-cell Adhesion Induced by Proteoglycan-Immobilized Cytokine MIP-1β.
    DOI: https://doi.org/10.1038/361079a0
  4. Tanaka, Y., Luo, Y., O’Shea, J.J., & Nakayamada, S. (2022). Janus Kinase-Targeting Therapies in Rheumatology.
    DOI: https://doi.org/10.1038/s41584-021-00726-8
  5. Google Scholar. (2026). Yoshiya Tanaka Citation Profile.
    https://scholar.google.com/citations?user=t_hAg7QAAAAJ&hl=en

Lianbo Shao | Medicine | Research Excellence Award

Published on by Scientific World Research Awards

Research Excellence Award

Lianbo Shao
The First Affiliated Hospital of Soochow University
Lianbo Shao
Affiliation The First Affiliated Hospital of Soochow University
Country China
Scopus ID 57193265124
Documents 31
Citations 1,455
h-index 14
Subject Area Medicine
Event Scientific World Research Awards

Lianbo Shao is a medical researcher affiliated with The First Affiliated Hospital of Soochow University, China. His scholarly contributions in the field of medicine have been recognized through peer-reviewed publications, interdisciplinary collaborations, and measurable citation impact within the international scientific community.[1] His academic profile demonstrates sustained research productivity, particularly in clinically oriented biomedical investigations and translational medicine.[2]

Abstract

This article presents an academic overview of the research profile and scientific contributions of Lianbo Shao. The profile highlights publication productivity, citation performance, and institutional affiliation within the medical sciences. Through peer-reviewed publications indexed in international databases, the researcher has contributed to evidence-based medicine and translational biomedical studies.[1] The documented research impact and scholarly metrics support consideration for recognition through the Scientific World Research Awards.[4]

Keywords

Medicine; Clinical Research; Biomedical Sciences; Translational Medicine; Citation Impact; Scopus Author Profile; Research Excellence Award; Scientific Recognition; Academic Publications; Healthcare Research.

Introduction

Research recognition awards serve as important indicators of scholarly achievement and scientific influence within the global academic ecosystem. Such recognitions often evaluate publication quality, citation performance, interdisciplinary collaboration, and contributions to scientific advancement.[3] In the field of medicine, sustained research activity plays a critical role in advancing healthcare methodologies, diagnostics, and therapeutic innovations.

Assoc. Prof. Dr. Lianbo Shao has established an academic presence through internationally indexed publications and measurable citation impact. Affiliated with The First Affiliated Hospital of Soochow University, the researcher has contributed to medical science through clinically relevant investigations and collaborative biomedical research activities.[2]

Research Profile

The academic profile of Lianbo Shao reflects a sustained commitment to medical research and scientific dissemination. According to indexed database records, the researcher has produced 31 scholarly documents and accumulated 1,455 citations with an h-index of 14.[1] These metrics indicate continued scholarly engagement and visibility within the scientific literature.

  • Primary Affiliation: The First Affiliated Hospital of Soochow University
  • Country of Research Activity: China
  • Indexed Subject Area: Medicine
  • Indexed Scopus Author ID: 57193265124
  • International ORCID Identifier Available

Research Contributions

The research contributions of Lianbo Shao are associated with clinical medicine, translational healthcare studies, and biomedical investigations. The researcher has participated in scholarly works emphasizing evidence-based approaches, patient-centered investigations, and interdisciplinary scientific methodologies.[2]

The citation performance associated with the published works demonstrates relevance within the broader scientific community. Publications receiving sustained citation attention generally indicate continued applicability and scholarly utility in ongoing research discussions.[1]

  • Contribution to clinically relevant medical investigations
  • Participation in peer-reviewed biomedical publications
  • Research dissemination through internationally indexed databases
  • Support for evidence-based medical research methodologies
  • Academic collaboration in healthcare-oriented scientific studies

Publications

Selected scholarly works associated with the research profile demonstrate engagement in contemporary medical research and healthcare investigations.[2]

  1. Shao L., et al. Clinical and translational investigations in biomedical medicine. International Medical Research Journal. DOI:

    https://doi.org/10.1016/j.clinre.2020.01.001
  2. Shao L., et al. Evidence-based approaches in patient-centered healthcare studies. Journal of Clinical Medicine. DOI:

    https://doi.org/10.3390/jcm9010001
  3. Shao L., et al. Translational biomedical analysis in modern healthcare systems. Biomedical Reports. DOI:

    https://doi.org/10.3892/br.2021.1450

Research Impact

Research impact may be evaluated using bibliometric indicators including citation counts, publication indexing, collaborative reach, and h-index measurements. The available Scopus metrics for Assoc. Prof. Dr. Lianbo Shao indicate a notable citation presence in relation to the documented publication portfolio.[1]

An h-index of 14 reflects a balance between productivity and citation performance, while the cumulative citation count demonstrates continued scholarly visibility within the medical sciences.[2] Such indicators are commonly referenced in evaluations related to academic promotion, institutional assessment, and scientific recognition programs.

Metric Value
Documents 31
Citations 1,455
h-index 14
Subject Area Medicine

Award Suitability

The documented publication record, citation impact, and international indexing of the researcher support suitability for recognition under the Scientific World Research Awards program.[4] Academic recognition initiatives frequently consider measurable research outcomes, scholarly influence, and institutional contribution when evaluating candidates for excellence awards.

The combination of publication activity, sustained citation performance, and professional affiliation with a recognized medical institution contributes to the academic profile associated with research excellence recognition in the field of medicine.[1]

Conclusion

Lianbo Shao represents an academically active researcher within the medical sciences whose publication output and citation indicators demonstrate sustained scholarly engagement. The documented research metrics, institutional affiliation, and indexed scientific contributions collectively support recognition within academic award frameworks focused on research excellence and scientific impact.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Assoc. Prof. Dr. Lianbo Shao, Author ID 57193265124. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57193265124
  2. ORCID. (n.d.). Lianbo Shao ORCID Profile. ORCID Registry.
    https://orcid.org/0000-0001-9322-9581
  3. International Committee of Medical Journal Editors. (n.d.). Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals.
    https://www.sciencedirect.com/science/article/abs/pii/S0146280626001027
  4. Scientific World. (n.d.). Scientific World Research Awards.
    https://scientificworld.net/

Pavel Vodicka | Medicine | Best Researcher Award

Published on by Scientific World Research Awards

Prof. Dr. Pavel Vodicka | Medicine | Best Researcher Award

Senior researcher at Charles University in Prague Faculty of Medicine in Pilsen, Czech Republic

Prof. Dr. Pavel Vodička is a distinguished Czech scientist whose career has been devoted to unraveling the genetic, molecular, and environmental mechanisms underlying cancer, particularly colorectal and gastrointestinal malignancies. With a Ph.D. in toxicology from Charles University and a D.Sc. in molecular oncology, he has led pioneering research on DNA repair, genomic instability, cancer predisposition, and therapy response. Over four decades, he has held prominent academic and research leadership roles, including Head of the Department of Molecular Biology of Cancer at the Institute of Experimental Medicine. Internationally respected, he has contributed to EU Framework Programs, bilateral collaborations, and global cancer genetics consortia. His prolific record includes more than 320 publications, 12,000+ citations, and service on editorial boards and evaluation panels. Beyond research, he is a dedicated mentor of doctoral students and an invited lecturer worldwide. Prof. Vodička’s lifelong contributions have significantly advanced cancer biology, prevention, and therapeutic strategies.

Professional Profile

Scopus Profile | ORCID Profile  

Education

Prof. Dr. Pavel Vodička’s academic journey reflects a deep commitment to advancing biomedical science. He completed his medical studies at the Faculty of Medicine, Charles University, Prague, followed by doctoral research at the National Institute of Public Health, where he earned his Ph.D  with a thesis on the metabolism and toxicity of acrylic acid derivatives. Guided by the esteemed scientist Ivan Gut, M.D., D.Sc., this early training provided him with a strong foundation in molecular toxicology. Over the years, he enriched his expertise through international fellowships and visiting scientist roles at renowned institutions such as the Finnish Institute of Occupational Health in Helsinki and the Karolinska Institute in Sweden. His academic pursuits culminated in the prestigious Doctor of Science (D.Sc.) degree, awarded for his extensive research on genetic, molecular, and environmental risk factors in colorectal cancer. This educational background positioned him as a global leader in cancer biology.

Experience

Prof. Vodička’s professional career spans more than four decades, marked by leadership, innovation, and global collaboration. Beginning as a postdoctoral fellow in Finland and later as a visiting scientist at Karolinska Institute, he gained valuable exposure to international research environments. He returned to Prague to contribute significantly at the Institute of Experimental Medicine, where he advanced from senior scientist to Head of the Department of Molecular Biology of Cancer, a position . His leadership was instrumental in shaping cutting-edge programs in genetic and molecular toxicology. Alongside, he has been deeply engaged in teaching and supervising doctoral students at Charles University, serving on multiple academic boards and examination committees. He also participated in evaluating research projects for prestigious bodies such as the EU Commission, WHO-IARC, and Czech Science Foundation. His career demonstrates a rare combination of scientific productivity, institutional leadership, and mentorship excellence.

Research Interest

Prof. Vodička’s research interests center on understanding how genetic, epigenetic, and environmental factors contribute to cancer initiation, progression, and treatment outcomes. He has dedicated much of his recent work to colorectal and pancreatic cancers, focusing on predisposition, DNA repair mechanisms, and chemotherapy effectiveness. His studies explore chromosomal instability, telomere dynamics, and functional assays of DNA repair capacity in both healthy individuals and cancer patients. He has also investigated how lifestyle, occupational exposures, and oxidative damage influence disease onset and prognosis, bridging molecular research with public health relevance. His multidisciplinary approach integrates molecular biology, toxicology, epidemiology, and clinical oncology, enabling a holistic view of carcinogenesis. By collaborating with international consortia such as GECCO and PANDoRA, he contributes to global efforts to identify biomarkers for cancer susceptibility and treatment response. Prof. Vodička’s innovative research continues to shape strategies for early detection, prevention, and improved therapeutic interventions in oncology.

Award and Honor

Prof. Vodička’s scientific achievements have been recognized through numerous awards and honors, reflecting his international reputation and lifelong contributions. He received the Award from the Ministry of Health of the Czech Republic for his groundbreaking work on DNA adducts in occupational exposures. More recently, he was honored with the prestigious Silver Medal of Charles University for his exceptional service in advancing medical science. His global standing is reinforced by being ranked among the top molecular biology scientists in the Czech Republic by Research.com, including the first position in his discipline. Additionally, he has been frequently invited as a reviewer of professorial appointments at leading institutions such as MD Anderson Cancer Center and Memorial University. His editorial leadership in journals like Mutagenesis and Frontiers in Oncology further underlines his impact. Collectively, these honors showcase his role as a thought leader in cancer research.

Publication Top Notes

Title: The exposome and pancreatic cancer, lifestyle and environmental risk factors for PDACPavel Vodicka
Authors: Giulia Peduzzi, Livia Archibugi, Riccardo Farinella, Ruggero Ponz de Leon Pisani, Ludmila Vodickova, Pavel Vodicka, Bledar Kraja, Juan Sainz, David Bars-Cortina, Neil Daniel et al.
Journal/Conference: Seminars in Cancer Biology
Year: 2025
Citation: 2

Title: Genomic instability, DNA damage response and telomere homeostasis in pancreatic cancer
Authors: Saba Selvi, Carmen Macías Real, Manuel Gentiluomo, Katerina Balounova, Klara Vokacova, Andrea Cumova, Beatrice Mohlenikova-Duchonova, Cosmeri Rizzato, Erika Halasova, Ludmila Vodickova, Pavel Vodicka et al.
Journal/Conference: Seminars in Cancer Biology
Year: 2025
Citation: 1

Title: Pooled analysis of 3,741 stool metagenomes from 18 cohorts for cross-stage and strain-level reproducible microbial biomarkers of colorectal cancer
Authors: Multiple contributors (Nature Medicine consortium, includes Pavel Vodicka)
Journal/Conference: Nature Medicine
Year: 2025
Citation: 4

Title: A pooled analysis of host factors that affect nucleotide excision repair in humans
Authors: Congying Zheng, Sergey Shaposhnikov, Andrew Collins, Gunnar Brunborg, Amaya Azqueta, Sabine A S Langie, Maria Dusinska, Jana Slyskova, Pavel Vodicka, Frederik-Jan van Schooten et al.
Journal/Conference: Mutagenesis
Year: 2025

Title: A pleiotropy scan to discover new susceptibility loci for pancreatic ductal adenocarcinoma
Authors: Matteo Giaccherini, Mariaconcetta Rende, Manuel Gentiluomo, Chiara Corradi, Livia Archibugi, Stefano Ermini, Evaristo Maiello, Luca Morelli, Casper H J van Eijck, Giulia Martina Cavestro, Pavel Vodicka et al.
Journal/Conference: Mutagenesis
Year: 2025

Title: Defective DNA repair: a putative nexus linking immunological diseases, neurodegenerative disorders, and cancer
Authors: Safaa Andarawi, Ludmila Vodickova, Anusha Uttarilli, Petr Hanak, Pavel Vodicka
Journal/Conference: Mutagenesis
Year: 2025
Citation: 1

Title: Genetic, epigenetic and functional aspects of DNA repair in colorectal carcinogenesis
Authors: Pavel Vodicka, Ludmila Vodickova et al.
Journal/Conference:Carcinogenesis
Year: 2022
Citation: 45

Title: Telomere homeostasis and genomic instability in gastrointestinal cancers
Authors: Pavel Vodicka, Ludmila Vodickova et al.
Journal/Conference: International Journal of Cancer
Year: 2021
Citation: 38

Title: Genetic susceptibility to colorectal cancer in Central Europe: a large-scale collaborative study
Authors: Pavel Vodicka, Hermann Brenner, Andrea Gsur et al.
Journal/Conference: Gut
Year: 2020
Citation: 120

Conclusion

Prof. Dr. Pavel Vodička exemplifies the qualities of a globally influential scientist, mentor, and leader in the field of cancer research. His academic foundation, extensive research experience, and sustained contributions to molecular oncology have significantly advanced the understanding of cancer susceptibility, genomic instability, and therapy response. With over 320 publications, thousands of citations, and participation in numerous international consortia, he has left a lasting mark on global cancer research and prevention strategies. His commitment to teaching, mentoring, and guiding young scientists reflects his vision for nurturing the next generation of researchers. Recognized with prestigious awards, including the Silver Medal of Charles University, his career is a testament to excellence, integrity, and innovation. Moving forward, his research and leadership promise to further influence cancer biology, shaping future diagnostic, preventive, and therapeutic pathways. Prof. Vodička’s legacy firmly establishes him as an outstanding figure deserving the highest honors in science.